Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intravenous oxytocin infusion versus late oxytocin bolus plus infusion during caesarean section
PACTR202404628293844Not yet recruiting
- Sponsor
- Shiru Mariam Motunrayo
- Start
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label trial of oxytocin (2 arms), sponsored by Shiru Mariam Motunrayo. Primary endpoint: Total blood loss at surgery. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on PACTR202404628293844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404628293844.